Health
Up Is Down — Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval – nejm.org
Perspective from The New England Journal of Medicine — Up Is Down — Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval
Nine pharmaceutical company leaders took the unprecedented step on September 8, 2020, of stating that they would refuse to apply for approval of a Covid-19 vaccine until adequate trial data are available.1 This announcement reflected an unusual role reversal at a time of unexpected regulatory anomalies. For decades, manufacturers have criticized the Food and Drug Administration (FDA) for being too slow and demanding too much evidence before approving new products. But in the face of growing publ…
-
Noosa News14 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General15 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News15 hours agoThe Best Things to Do in Brisbane This New Year’s Eve
-
Noosa News19 hours agoMary River cod thriving in Brisbane River catchment, century after relative went extinct